Chemopreventive effect of a mixture of Chinese Herbs (antitumor B) on chemically induced oral carcinogenesis

Molecular Carcinogenesis

Volumn 52, Issue 1, 2013, Pages 49-56

  Wang, Yian ^a   Yao, Ruisheng ^a   Gao, Song ^b   Wen, Weidong ^a   Du, Yinqiu ^a   Szabo, Eva ^c   Hu, Ming ^b   Lubet, Ronald A ^c   You, Ming ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Antitumor B; Chemoprevention; Oral cancer

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; ANTINEOPLASTIC AGENT; ANTITUMOR B; EPIDERMAL GROWTH FACTOR RECEPTOR; MAACKIAIN; MATRINE; OBACUNONE; PTEROCARPAN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CHINESE HERB; CONTROLLED STUDY; DICTAMNUS DASYCARPUS; DIOSCOREA BULBIFERA; DOWN REGULATION; DRUG DISTRIBUTION; DRUG EFFICACY; MOUSE; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; POLYGONUM BISTORTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PRUNELLA VULGARIS; SONCHUS ARVENSIS; SOPHORA TONKINENSIS; STEADY STATE;

4-NITROQUINOLINE-1-OXIDE; ALKALOIDS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BENZOXEPINS; BIOLOGICAL MARKERS; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHEMOPREVENTION; DRUGS, CHINESE HERBAL; LIMONINS; MALE; MICE; MOUTH NEOPLASMS; PHOSPHORYLATION; PTEROCARPANS; QUINOLIZINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TYROSINE;

DICTAMNUS DASYCARPUS; DIOSCOREA BULBIFERA; MUS; POLYGONUM BISTORTA; PRUNELLA VULGARIS; SONCHUS ARVENSIS; SOPHORA;

EID: 84871344756     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20877     Document Type: Article

References (35)

1. Andre K, Schraub S, Mercier M, Bontemps P. Role of alcohol and tobacco in the aetiology of head and neck cancer: A case-control study in the Doubs region of France. Eur J Cancer B Oral Oncol 1995; 31B: 301-309.
2. Iribarren C, Tekawa IS, Sidney S, Friedman GD. Effect of cigar smoking on the risk of cardiovascular disease, chronic obstructive pulmonary disease, and cancer in men. N Engl J Med 1999; 340: 1773-1780.
3. Murata M, Takayama K, Choi BC, Pak AW. A nested case-control study on alcohol drinking, tobacco smoking, and cancer. Cancer Detect Prev 1996; 20: 557-565.
4. Spitz MR. Epidemiology and risk factors for head and neck cancer. Semin Oncol 1994; 21: 281-288 (Review).
5. Winn DM. Smokeless tobacco and aerodigestive tract cancers: Recent research directions. Adv Exp Med Biol 1992; 320: 39-46 (Review).
6. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
7. Christensen ME, Therkildsen MH, Hansen BL, Albeck H, Hensen GN, Bretlau P. Epidermal growth factor receptor expression on oral mucosa dysplastic epithelia and squamous cell carcinoma. Eur Arch Otorhinolaryngol 1992; 249: 243-247.
8. Hiraishi Y, Wada T, Nakatani K, Negoro K, Fujita S. Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas. Pathol Oncol Res 2006; 12: 87-91.
9. Laimer K, Spizzo G, Gastl G, et al. High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: A TMA-based immunohistochemical analysis. Oral Oncol 2007; 43: 193-198.
10. Sarkis SA, Abdullah BH, Abdul Majeed BA, Talabani NG. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in oral squamous cell carcinoma in relation to proliferation, apoptosis, angiogenesis and lymphangiogenesis. Head Neck Oncol 2010; 2: 13.
11. Forastiere AA, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med 2002; 345: 1890-1900.
12. Zhang Z, Wang Y, Yao R, Lubet RA, You M. p53 transgenic mice are highly susceptible to 4-nitroquinoline-1-oxide-induced oral cancer. Mol Cancer Res 2006; 4: 401-410.
13. Steidler NE, Reade PC. Experimental induction of oral squamous cell carcinomas in mice with 4-nitroquinoline-1-oxide. Oral Surg Oral Med Oral Pathol 1984; 57: 524-531.
14. Yuan B, Heniford BW, Ackermann DM, Hawkins BL, Hendler FJ. Harvey ras (H-ras) point mutations are induced by 4-nitroquinoline-1-oxide in murine oral squamous epithelia, while squamous cell carcinomas and loss of heterozygosity occur without additional exposure. Cancer Res 1996; 54: 5310-5317.
15. Wang Y, Zhang Z, Yao R, et al. Prevention of lung cancer progression by bexarotene in mouse models. Oncogene 2006; 25: 1320-1329.
16. Fu YY, Zhou X, Hou MJ, Gao HY. Tablet of Zengshengping. Zhong yao xin yao yu lin chuang yao li 1998; 9: 124.
17. Zhang LP, Jiang JK, Tam JW, et al. Effects of Matrine on proliferation and differentiation in K-562cells. Leuk Res 2001; 25: 793-800.
18. Dai ZJ, Gao J, Ji ZZ, et al. Matrine induces apoptosis in gastric carcinoma cells via alteration of Fas/FasL and activation of caspase-3. J Ethnopharmacol 2009; 123: 91-96.
19. Fan X. Inhibitory effect of antitumor-B and retinamide on precancerous lesions of the bladder in rats. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 1993; 15: 71-73.
20. Zhang Y, Wang S, Li Y, Xiao Z, Hu Z, Zhang J. Sophocarpine and matrine inhibit the production of TNF-alpha and IL-6 in murine macrophages and prevent cachexia-related symptoms induced by colon26 adenocarcinoma in mice. Int Immunopharmacol 2008; 8: 1767-1772.
21. Ma LD, Zhang Y, Wen SH, et al. Inhibition of tumor growth in tumor-bearing mice treated with matrine. Zhonghua Zhong Liu Za Zhi 2005; 27: 339-341 [Article in Chinese].
22. Zhang R, Jing T. An approach to the mechanism of matrine and albendazole against Echinococcus multilocularis infection in mice. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2006; 24: 366-369 [Article in Chinese].
23. Tanaka T, Kohno H, Tsukio Y, et al. Citrus limonoids obacunone and limonin inhibit azoxymethane-induced colon carcinogenesis in rats. Biofactors 2000; 13: 213-218.
24. Tanaka T, Maeda M, Kohno H, et al. Inhibition of azoxymethane-induced colon carcinogenesis in male F344 rats by the citrus limonoids obacunone and limonin. Carcinogenesis 2001; 22: 193-198.
25. Zhang Z, Wang Y, Yao R, et al. Cancer chemopreventive activity of a mixture of Chinese herbs (antitumor B) in mouse lung tumor models. Oncogene 2004; 23: 3841-3850.
26. Wang Y, Zhang Z, Garbow JR, et al. Chemoprevention of lung squamous cell carcinoma in mice by a mixture of Chinese herbs. Cancer Prev Res (PhilaPa) 2009; 2: 634-640.
27. Lin P, Zhang J, Rong Z, et al. Studies on medicamentous inhibitory therapy for esophageal precancerous lesions-3- and 5-year inhibitory effects of antitumor-B, retinamide and riboflavin. Proc Chin Acad Med Sci Peking Union Med Coll 1990; 5: 121-129.
28. Gao GH, Law FCP. Physiologically based pharmacokinetics of matrine in the rat after oral administration of pure chemical and ACAPHA. Drug Metab Disp 2009; 37: 884-892.
29. Grandis JR, Sok JC. Signaling through the epidermal growth factor receptor during the development of malignancy. Pharmacol Ther 2004; 102: 37-46.
30. Nicholas MK, Lukas RV, Jafri NF, Faoro L, Salgia R. Epidermal growth factor receptor-mediated signal transduction in the development and therapy of gliomas. Clin Cancer Res 2006; 12: 7261-7270.
31. Sebastian S, Settleman J, Reshkin SJ, Azzariti A, Bellizzi A, Paradiso A. The complexity of targeting EGFR signalling in cancer: From expression to turnover. Biochim Biophys Acta 2006; 1766: 120-139.
32. Partridge M, Gullick WJ, Langdon JD, Sherriff M. Expression of epidermal growth factor receptor on oral squamous cell carcinoma. Br J Oral Maxillofac Surg 1988; 26: 381-389.
33. Xia W, Lau YK, Zhang HZ, et al. Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin Cancer Res 1999; 5: 4164-4174.
34. Sheikh Ali MA, Gunduz M, Nagatsuka H, et al. Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma. Cancer Sci 2008; 99: 1589-1594.
35. Sun Z, Sood S, Li N, et al. Chemoprevention of 7, 12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch by topical application of a dual inhibitor of epidermal growth factor receptor (EGFR) and ErbB2 tyrosine kinases. Oral Oncol 2008; 44: 652-657.